|Recombinant Human VEGF 183 / VEGF-A protein (Catalog#10009-HNAB)|
|0.2 μm filtered solution in PBS with 5% trehalose|
|Produced in rabbits immunized with purified, recombinant Human VEGF 183 / VEGF-A (rh VEGF 183 / VEGF-A; Catalog#10009-HNAB; P15692-3; Met 1-Arg 209). VEGF 183 / VEGF-A specific IgG was purified by Human VEGF 183 / VEGF-A affinity chromatography.|
WB: 0.1-0.2 μg/ml
ELISA: 0.1-0.2 μg/mL
This antibody can be used at 0.1-0.2 μg/mL with the appropriate secondary reagents to detect Human VEGF183. The detection limit for Human VEGF183 is approximately 0.00975 ng/well.
IHC-P: 0.1-2 μg/mL
Vascular endothelial growth factor (VEGF), also known as vascular permeability factor (VPF) and VEGF-A, is a potent mediator of both angiogenesis and vasculogenesis in the fetus and adult. It is a member of the platelet-derived growth factor (PDGF)/vascular endothelial growth factor (VEGF) family and often exists as a disulfide-linked homodimer. VEGF-A protein is a glycosylated mitogen that specifically acts on endothelial cells and has various effects, including mediating increased vascular permeability, inducing angiogenesis, vasculogenesis and endothelial cell growth, promoting cell migration, inhibiting apoptosis and tumor growth. VEGF-A protein is also a vasodilator that increases microvascular permeability, thus it was originally referred to as vascular permeability factor.